{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T12:56:55Z","timestamp":1769345815150,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"GenVec, Inc.","award":["HSHQPD-07-X-00003"],"award-info":[{"award-number":["HSHQPD-07-X-00003"]}]},{"DOI":"10.13039\/100015624","name":"Leidos","doi-asserted-by":"crossref","award":["HSHQDC-14-F-00035"],"award-info":[{"award-number":["HSHQDC-14-F-00035"]}],"id":[{"id":"10.13039\/100015624","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The McConnell Group, Inc.","award":["HSHQDC-8-C-00011"],"award-info":[{"award-number":["HSHQDC-8-C-00011"]}]},{"name":"Benchmark Biolabs","award":["HSHQDC-12-C-00127"],"award-info":[{"award-number":["HSHQDC-12-C-00127"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.vaccine.2018.10.031","type":"journal-article","created":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T09:07:27Z","timestamp":1539421647000},"page":"7345-7352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine"],"prefix":"10.1016","volume":"36","author":[{"given":"Jos\u00e9","family":"Barrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Brake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Schutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damodar","family":"Ettyreddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5667-8027","authenticated-orcid":false,"given":"Barbara J.","family":"Kamicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max V.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Bravo de Rueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariceny","family":"Zurita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melia","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Hurtle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas E.","family":"Brough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan T.","family":"Butman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce G.","family":"Harper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0360-5040","authenticated-orcid":false,"given":"John G.","family":"Neilan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2018.10.031_b0005","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/tbed.12507","article-title":"Foot-and-mouth disease impact on smallholders \u2013 what do we know, what don't we know and how can we find out more?","volume":"64","author":"Knight-Jones","year":"2017","journal-title":"Transbound Emerg Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.10.031_b0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/tbed.12522","article-title":"Global foot-and-mouth disease research update and gap analysis: 2 \u2013 epidemiology, wildlife and economics","volume":"63","author":"Knight-Jones","year":"2016","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2018.10.031_b0015","unstructured":"Garner G. Foot-and-mouth disease situation: Food and Agriculture Organization of the United Nations; 2017 [Available from: http:\/\/www.fao.org\/fileadmin\/user_upload\/eufmd\/docs\/FMD_monthly_reports\/2017\/Nov_GMR_2017.pdf]."},{"key":"10.1016\/j.vaccine.2018.10.031_b0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coviro.2018.02.005","article-title":"The need for improved vaccines against foot-and-mouth disease","volume":"29","author":"de Los","year":"2018","journal-title":"Curr Opin Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.10.031_b0025","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1006\/viro.1999.9940","article-title":"Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate","volume":"263","author":"Mayr","year":"1999","journal-title":"Virology"},{"issue":"27","key":"10.1016\/j.vaccine.2018.10.031_b0030","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1016\/j.vaccine.2015.12.018","article-title":"Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge","volume":"34","author":"Schutta","year":"2016","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2018.10.031_b0035","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.vaccine.2018.01.026","article-title":"Use of ENABL(R) adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine","volume":"36","author":"Barrera","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2018.10.031_b0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/tbed.12724","article-title":"Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle","volume":"65","author":"Barrera","year":"2018","journal-title":"Transbound Emerg Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2018.10.031_b0045","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1128\/jvi.70.9.6497-6501.1996","article-title":"A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4","volume":"70","author":"Brough","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.10.031_b0050","first-page":"123","article-title":"Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing","volume":"134","author":"Brake","year":"2012","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2018.10.031_b0055","unstructured":"OIE. Foot and mouth disease. Chapter 2.1.5. Paris, France: World Organisation for Animal Health; 2012. Available from: http:\/\/www.oie.int\/fileadmin\/Home\/eng\/Health_standards\/tahm\/2008\/pdf\/2.01.05_FMD.pdf."},{"issue":"2","key":"10.1016\/j.vaccine.2018.10.031_b0060","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1128\/JCM.03220-14","article-title":"A continuous bovine kidney cell line constitutively expressing bovine alphaVbeta6 integrin has increased susceptibility to foot-and-mouth disease virus","volume":"53","author":"LaRocco","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.10.031_b0065","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1128\/JCM.03370-12","article-title":"A continuous bovine kidney cell line constitutively expressing bovine alphavbeta6 integrin has increased susceptibility to foot-and-mouth disease virus","volume":"51","author":"LaRocco","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.031_b0070","unstructured":"OIE. Infection with foot and mouth disease virus. Chapter 8.8. Paris, France. 2016. Available from: http:\/\/www.oie.int\/fileadmin\/Home\/eng\/Health_standards\/tahc\/current\/chapitre_fmd.pdf. [accessed 26 September 2018]."},{"issue":"11","key":"10.1016\/j.vaccine.2018.10.031_b0075","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2460\/javma.2002.220.1636","article-title":"Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus","volume":"220","author":"Callahan","year":"2002","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2018.10.031_b0080","series-title":"Vaccine manual. The production and quality control of veterinary vaccines for use in developing countries","article-title":"Potency assessment of inactivated viral vaccinesPotency assessment of inactivated viral vaccines","author":"Doel","year":"1997"},{"key":"10.1016\/j.vaccine.2018.10.031_b0085","series-title":"R: a language and environment for statistical computing","author":"R Development Core Team","year":"2018"},{"key":"10.1016\/j.vaccine.2018.10.031_b0090","unstructured":"Bates DM, Maechler M, Bolker B. lme4: Linear mixed-effects models using S4 classes. R package version R 3.0.1; 2012."},{"key":"10.1016\/j.vaccine.2018.10.031_b0095","unstructured":"Faraway JJ. Practical Regression and ANOVA using R. 2002. http:\/\/cran.r-project.org\/doc\/contrib\/Faraway-PRA.pdf [accessed 25 September 2018]."},{"issue":"2","key":"10.1016\/j.vaccine.2018.10.031_b0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/0049124104268644","article-title":"Multimodel inference: understanding AIC and BIC in model selection","volume":"33","author":"Burnham","year":"2004","journal-title":"Sociol Methods Res"},{"issue":"11","key":"10.1016\/j.vaccine.2018.10.031_b0105","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.vaccine.2009.12.065","article-title":"Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve","volume":"28","author":"Cox","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.031_b0110","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1743-422X-4-122","article-title":"Genetic characterisation of the recent foot-and-mouth disease virus subtype A\/IRN\/2005","volume":"4","author":"Klein","year":"2007","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2018.10.031_b0115","unstructured":"Knowles NJ. Molecular Epidemiology Report Form. IAH-P-EP-MEG-FOR-005-1. United Kingdom: The Pirbright Institute; 2005 [Available from: http:\/\/www.wrlfmd.org\/fmd_genotyping\/2005\/WRLFMD-2005-00012-Iran-A.pdf. [accessed 26 September 2018]."},{"issue":"5","key":"10.1016\/j.vaccine.2018.10.031_b0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1865-1682.2009.01074.x","article-title":"Recent spread of a new strain (A-Iran-05) of foot-and-mouth disease virus type A in the Middle East","volume":"56","author":"Knowles","year":"2009","journal-title":"Transbound Emerg Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2018.10.031_b0125","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.vaccine.2018.02.016","article-title":"Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A\/ASIA\/G-VII lineage","volume":"36","author":"Waters","year":"2018","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2018.10.031_b0130","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3201\/eid1310.070252","article-title":"Foot-and-mouth disease virus serotype A in Egypt","volume":"13","author":"Knowles","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2018.10.031_b0135","doi-asserted-by":"crossref","first-page":"694","DOI":"10.5455\/vetworld.2012.693-703","article-title":"Update on epidemiology and control of foot and mouth disease \u2013 A menace to international trade and global animal enterprise","volume":"5","author":"Depa","year":"2012","journal-title":"Vet World"},{"issue":"45","key":"10.1016\/j.vaccine.2018.10.031_b0140","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1016\/j.vaccine.2008.08.022","article-title":"Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine","volume":"26","author":"Pena","year":"2008","journal-title":"Vaccine"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2018.10.031_b0145","first-page":"1","article-title":"Targeted adenoviral vectors","volume":"1575","author":"Barnett","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"10.1016\/j.vaccine.2018.10.031_b0150","doi-asserted-by":"crossref","first-page":"13407","DOI":"10.1128\/JVI.77.24.13407-13411.2003","article-title":"Detailed analysis of the CD8+ T-cell response following adenovirus vaccination","volume":"77","author":"Yang","year":"2003","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.10.031_b0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1128\/CVI.00426-15","article-title":"Evaluation of a fiber-modified adenovirus vector vaccine against foot-and-mouth disease in cattle","volume":"23","author":"Medina","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"46","key":"10.1016\/j.vaccine.2018.10.031_b0160","doi-asserted-by":"crossref","first-page":"8230","DOI":"10.1016\/j.vaccine.2011.08.120","article-title":"Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009\u20132010 and cross-protection studies with the vaccine strain in use in the region","volume":"29","author":"Maradei","year":"2011","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.vaccine.2018.10.031_b0165","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1016\/j.vaccine.2016.06.073","article-title":"Protection induced by a commercial bivalent vaccine against Foot-and-Mouth Disease 2010 field virus from Ecuador","volume":"34","author":"Duque","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2018.10.031_b0170","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/tbed.12373","article-title":"Review of the global distribution of foot-and-mouth disease virus from 2007 to 2014","volume":"64","author":"Brito","year":"2017","journal-title":"Transbound Emerg Dis"},{"issue":"51","key":"10.1016\/j.vaccine.2018.10.031_b0175","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.1016\/j.vaccine.2017.10.099","article-title":"Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007\u20132012) circulating in Southeast Asia, East Asia and Far East","volume":"35","author":"Mahapatra","year":"2017","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2018.10.031_b0180","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/tbed.12109","article-title":"Epidemiology of the foot-and-mouth disease Serotype O epidemic of november 2010 to april 2011 in the Republic of Korea","volume":"62","author":"Yoon","year":"2015","journal-title":"Transbound Emerg Dis"},{"issue":"38","key":"10.1016\/j.vaccine.2018.10.031_b0185","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1016\/j.vaccine.2017.07.102","article-title":"Protective effects of high-potency FMDV O1 Manisa monovalent vaccine in cattle challenged with FMDV O\/SKR\/2010 at 7 or 4 days post vaccination","volume":"35","author":"Horsington","year":"2017","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2018.10.031_b0190","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.vaccine.2015.04.045","article-title":"Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination","volume":"33","author":"Wilna","year":"2015","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2018.10.031_b0195","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.vaccine.2014.01.067","article-title":"Protection to homologous and heterologous challenge in pigs immunized with vaccine against foot-and-mouth disease type O caused an epidemic in East Asia during 2010\/2011","volume":"32","author":"Park","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2018.10.031_b0200","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1292\/jvms.16-0482","article-title":"Experimental infections using the foot-and-mouth disease virus O\/JPN\/2010 in animals administered a vaccine preserved for emergency use in Japan","volume":"79","author":"Fukai","year":"2017","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2018.10.031_b0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.virol.2016.12.021","article-title":"Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine","volume":"502","author":"Fernandez-Sainz","year":"2017","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2018.10.031_b0210","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.vaccine.2018.02.015","article-title":"Efficacy of a high quality O1\/Campos foot-and-mouth disease vaccine upon challenge with a heterologous Korean O Mya98 lineage virus in pigs","volume":"36","author":"Galdo Novo","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.031_b0215","unstructured":"Hammond J. OIE\/FAO FMD Reference Laboratory Network. Annual Report 2011. 2012 [Available from: http:\/\/www.wrlfmd.org\/ref_labs\/ref_lab_reports\/OIE-FAO%20FMD%20Ref%20Lab%20Network%20Report%202011.pdf. [accessed 26 September 2018]."},{"key":"10.1016\/j.vaccine.2018.10.031_b0220","unstructured":"Li Y, Statham B, Armson B, Hamblin P, Wilsden G, Camping N, et al. Cross protection against current Asia 1 isolates provided by a high potency Asia 1 Shamir vaccine Jerez, Spain.2012 [Available from: http:\/\/www.fao.org\/fileadmin\/user_upload\/eufmd\/docs\/Open_Session2012\/Appendices\/27_Cross_protection_against_current_Asia_1_field_isolates_provided_by_a_high_potency_Asia_1_Shamir_vaccine___Y._Li_.pdf. [accessed 26 September 2018]."},{"issue":"16","key":"10.1016\/j.vaccine.2018.10.031_b0225","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.vaccine.2014.01.071","article-title":"Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey","volume":"32","author":"Knight-Jones","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2018.10.031_b0230","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/tbed.12015","article-title":"Emergence of foot-and-mouth disease virus SAT 2 in Egypt during 2012","volume":"59","author":"Ahmed","year":"2012","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2018.10.031_b0235","series-title":"FAO World Reference Laboratory for Foot-and-Mouth Disease (WRLFMD)","author":"Bankowska","year":"2017"},{"issue":"5","key":"10.1016\/j.vaccine.2018.10.031_b0240","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1177\/1040638718779641","article-title":"An improved, rapid competitive ELISA using a novel conserved 3B epitope for the detection of serum antibodies to foot-and-mouth disease virus","volume":"30","author":"Chung","year":"2018","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2018.10.031_b0245","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.vetmic.2017.03.019","article-title":"Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle","volume":"203","author":"Sreenivasa","year":"2017","journal-title":"Vet Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18313975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18313975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:28:54Z","timestamp":1759400934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18313975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":49,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0264410X18313975"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}